Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126122723 | 12612272 | 3 | F | 20160425 | 20160920 | 20160801 | 20160926 | EXP | JP-ELI_LILLY_AND_COMPANY-JP201605005346 | ELI LILLY AND CO | 70.48 | YR | M | Y | 70.00000 | KG | 20160926 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126122723 | 12612272 | 1 | PS | CYRAMZA | RAMUCIRUMAB | 1 | Intravenous (not otherwise specified) | 560 MG, OTHER | Y | 125477 | 560 | MG | INJECTION | ||||||
| 126122723 | 12612272 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 130 MG, OTHER | Y | 0 | 130 | MG | |||||||
| 126122723 | 12612272 | 3 | C | BAYASPIRIN | ASPIRIN | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 126122723 | 12612272 | 4 | C | BAYASPIRIN | ASPIRIN | 1 | 0 | TABLET | |||||||||||
| 126122723 | 12612272 | 5 | C | EQUA | VILDAGLIPTIN | 1 | Oral | UNK | 0 | TABLET | |||||||||
| 126122723 | 12612272 | 6 | C | IRTRA | IRBESARTANTRICHLORMETHIAZIDE | 1 | Oral | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126122723 | 12612272 | 1 | Gastric cancer stage IV |
| 126122723 | 12612272 | 2 | Gastric cancer stage IV |
| 126122723 | 12612272 | 3 | Hypertension |
| 126122723 | 12612272 | 4 | Diabetes mellitus |
| 126122723 | 12612272 | 5 | Diabetes mellitus |
| 126122723 | 12612272 | 6 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126122723 | 12612272 | OT |
| 126122723 | 12612272 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126122723 | 12612272 | Febrile neutropenia | |
| 126122723 | 12612272 | Hypoalbuminaemia | |
| 126122723 | 12612272 | Interstitial lung disease | |
| 126122723 | 12612272 | Liver function test increased | |
| 126122723 | 12612272 | Malignant ascites | |
| 126122723 | 12612272 | Oral candidiasis | |
| 126122723 | 12612272 | Platelet count decreased | |
| 126122723 | 12612272 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126122723 | 12612272 | 1 | 20160413 | 20160413 | 0 | |
| 126122723 | 12612272 | 2 | 20160413 | 20160420 | 0 | |
| 126122723 | 12612272 | 3 | 20160425 | 0 | ||
| 126122723 | 12612272 | 5 | 20160425 | 0 | ||
| 126122723 | 12612272 | 6 | 20160425 | 0 |